# Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke

> **NCT07365475** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Tianjin Huanhu Hospital** · enrollment: 306 (estimated)

## Conditions studied

- Acute Ischemic Stroke From Large Vessel Occlusion

## Interventions

- **DRUG:** 20% human serum albumin

## Key facts

- **NCT ID:** NCT07365475
- **Lead sponsor:** Tianjin Huanhu Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-30
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-08-30
- **Target enrollment:** 306 (ESTIMATED)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07365475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07365475, "Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07365475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*